Pregnancy after a diagnosis of estrogen receptor-positive breast cancer does not affect prognosis

被引：1
|
作者：
Barton, Mary Kay
机构：
来源：
CA-A CANCER JOURNAL FOR CLINICIANS | 2013年 / 63卷 / 03期
关键词：
D O I：
10.3322/caac.21178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：143 / 144
页数：4
相关论文
共 50 条
  • [31] The impact of CBP expression in estrogen receptor-positive breast cancer
    Ramadan, Wafaa S.
    Talaat, Iman M.
    Hachim, Mahmood Y.
    Lischka, Annette
    Gemoll, Timo
    El-Awady, Raafat
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [32] The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer
    Kwa, Maryann
    Plottel, Claudia S.
    Blaser, Martin J.
    Adams, Sylvia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08):
  • [33] Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
    Yom, Cha Kyong
    Lee, Kyung-Min
    Han, Wonshik
    Kim, Sung-Won
    Kim, Hee Sung
    Moon, Byung In
    Jeong, Ku-Young
    Im, Seock-Ah
    Noh, Dong-Young
    JOURNAL OF BREAST CANCER, 2013, 16 (02) : 138 - 145
  • [34] One Way or Another: An Oligorecurrence After an Oligometastasis of an Estrogen Receptor-Positive Breast Cancer
    Goodman, Chelain R.
    Strauss, Jonathan B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 571 - 572
  • [35] Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Katsuta, Eriko
    Dasgupta, Subhamoy
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S34 - S34
  • [36] Role of SALL4 and Nodal in the prognosis and tamoxifen resistance of estrogen receptor-positive breast cancer
    Boustan, Arad
    Mosaffa, Fatemeh
    Jahangiri, Rosa
    Heidarian-Miri, Hamid
    Dahmardeh-Ghalehno, Asefeh
    Jamialahmadi, Khadijeh
    MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2021, 10 (03) : 109 - 119
  • [37] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Wen-Ting Peng
    Xin Hu
    Ling Yao
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Annals of Surgical Oncology, 2014, 21 : 648 - 656
  • [38] Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer
    Abubakar, Mustapha
    Mullooly, Maeve
    Nyante, Sarah
    Pfeiffer, Ruth M.
    Bowles, Erin J. Aiello
    Cora, Renata
    Bodelon, Clara
    Butler, Ebonee
    Butcher, Donna
    Sternberg, Lawrence
    Troester, Melissa A.
    Weinmann, Sheila
    Sherman, Mark
    Glass, Andrew G.
    de Gonzalez, Amy Berrington
    Gierach, Gretchen L.
    JNCI CANCER SPECTRUM, 2022, 6 (03)
  • [39] High Ezrin Expression Is Linked To Poor Prognosis and Drug Resistance in Estrogen Receptor-Positive Breast Cancer
    Vanna, Sonal
    Hoskin, Victoria
    Ghaffari, Abdi
    Madarnas, Yolanda
    SenGupta, Sandip
    Elliott, Bruce
    LABORATORY INVESTIGATION, 2015, 95 : 71A - 71A
  • [40] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Peng, Wen-Ting
    Hu, Xin
    Yao, Ling
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S648 - S656
12345